{"transactions":[{"id":2502624,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":9.22,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502623,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502622,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":11.74,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502621,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":28.14,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502620,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":20.16,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502619,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":13.83,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502618,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":21.85,"expiration_date":"2025-06-16","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502617,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":17.61,"expiration_date":"2024-03-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502616,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":250,"price":8.5,"value":2125.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502615,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":19653,"price":8.5,"value":167050.5,"ownership":{"direct":false,"nature":"By Colella Partners II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares held by Colella Partners II. The Reporting Person is the general partner of Colella Partners II."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502614,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":943,"price":8.5,"value":8015.5,"ownership":{"direct":false,"nature":"By Colella Partners"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by Colella Partners. The Reporting Person is the general partner of Colella Partners."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502613,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":388683,"price":8.5,"value":3303805.5,"ownership":{"direct":false,"nature":"By Versant Development Fund III, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held by Versant Development Fund III, LLC (\"Development III\").  The Reporting Person is a managing member of VV III, a majority member of Development III and shares voting and dispositive power over the shares held by Development III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502612,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":5871,"price":8.5,"value":49903.5,"ownership":{"direct":false,"nature":"By Versant Side Fund III"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held by Versant Side Fund III, L.P. (\"Side Fund III\").  The Reporting Person is a managing member of VV III, the sole general partner of Side Fund III and shares voting and dispositive power over the shares held by Side Fund III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502611,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":994129,"price":8.5,"value":8450096.5,"ownership":{"direct":false,"nature":"By Versant Venture Capital III L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held by Versant Venture Capital III, L.P. (\"VVC III\").  The Reporting Person is a managing member of Versant Ventures III, LLC (\"VV III\"), the sole general partner of VVC III and shares voting and dispositive power over the shares held by VVC III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502610,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":8.5,"value":42500.0,"ownership":{"direct":false,"nature":"By the Colella Family Exempt Marital Deduction Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held by the Colella Family Exempt Marital Deduction Trust Dated 9/21/1992 (\"Colella Exempt Trust\"). The Reporting Person is a trustee and beneficiary of the Colella Exempt Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502609,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":72035,"price":8.5,"value":612297.5,"ownership":{"direct":false,"nature":"By the Colella Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"shares","element":"transactionShares","label":"F3","text":"2,198 shares were inadvertently reported as held directly by the Reporting Person.  The shares are held by the Colella Family Trust UTA dtd 9/21/92."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 (\"Colella Trust\"). The Reporting Person is a trustee and beneficiary of the Colella Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502608,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":1000,"price":8.5,"value":8500.0,"ownership":{"direct":false,"nature":"The Samuel Colella Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2502607,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:12:26.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"price":8.5,"value":76500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, each outstanding restricted stock unit award (\"RSU\") was accelerated and became fully vested and was cancelled and converted into the right to receive (i) $8.50 per share of Issuer common stock issuable in settlement of such RSU in cash, net of any withholding taxes required to be deducted and withheld by applicable law, plus (ii) any potential CVR Payments."},{"field":"shares","element":"transactionShares","label":"F3","text":"2,198 shares were inadvertently reported as held directly by the Reporting Person.  The shares are held by the Colella Family Trust UTA dtd 9/21/92."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065716/doc4.xml","form_type":"4"}},{"id":2653291,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-06-28T18:32:52.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":9.22,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-043553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043553/doc4.xml","form_type":"4"}},{"id":2653290,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T18:32:52.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 1,000 shares to The Samuel Colella Trust."}],"balance_after":11198,"source":{"system":"sec-edgar","filing":"0001209191-21-043553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043553/doc4.xml","form_type":"4"}},{"id":2791735,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T17:10:12.000Z","date":"2021-01-15","kind":"other","acquired":true,"shares":2198,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a change in the form of ownership of the Colella Family Trust UTA Dtd. 9/21/92 (\"Colella Trust\") by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Side Fund III, L.P. to its partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"24,504 shares held by the Reporting Person were inadvertently reported on prior Form 4 filings as held directly. Instead, the shares are held by the Reporting Person indirectly in the name of the Colella Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"2,198 shares were inadvertently reported as held by the Colella Trust. The shares are held directly by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the Colella Trust. The Reporting Person, a member of the Issuer's board of directors, is a trustee and beneficiary of the Colella Trust."}],"balance_after":69837,"source":{"system":"sec-edgar","filing":"0001209191-21-020224","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121020224/doc4a.xml","form_type":"4/A","original_submission_date":"2021-01-20"}},{"id":2902123,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":true,"shares":943,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a change in the form of ownership of Colella Family Partners (\"Colella Partners\") by virtue of the receipt of shares in the pro-rata distribution of common stock of the Issuer for no consideration by VSF III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Shares held by Colella Partners. The Reporting Person is the general partner of Colella Partners."}],"balance_after":943,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":2902122,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":true,"shares":2198,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a change in the form of ownership of the Colella Family Trust UTA Dtd. 9/21/92 (\"Colella Trust\") by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VSF III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Shares held by Colella Trust. The Reporting Person, a member of the Issuer's board of directors, is a trustee and beneficiary of the Colella Trust."}],"balance_after":47531,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":2902121,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":false,"shares":14868,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund III, L.P. (\"VSF III\"), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VSF III. VV III is the sole general partner of VSF III. The Reporting Person, a member of the Issuer's board of directors, is a managing member of VV III and may be deemed to share voting and dispositive power over the shares held by VSF III. Each of VV III and the Reporting Person disclaims beneficial ownership of the shares held by VSF III, except to the extent of their respective pecuniary interests therein."}],"balance_after":5871,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":2902120,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":true,"shares":19653,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Colella Partners II, L.P. (\"Colella Partners II\") by virtue of the receipt of shares in the pro-rata distribution of common stock of the Issuer for no consideration by VV III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Colella Partners II. The Reporting Person is the general partner of Colella Partners II."}],"balance_after":19653,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":2902119,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":false,"shares":648266,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV III, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV III. The Reporting Person, a member of the Issuer's board of directors, is a managing member of VV III and may be deemed to share voting and dispositive power over the shares held by VV III; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":2902118,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":true,"shares":648266,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV III by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VVC III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV III. The Reporting Person, a member of the Issuer's board of directors, is a managing member of VV III and may be deemed to share voting and dispositive power over the shares held by VV III; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":648266,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":2902117,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T19:09:50.000Z","date":"2021-01-15","kind":"other","acquired":false,"shares":2517541,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital III, L.P. (\"VVC III\"), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by VVC III. Versant Ventures III, LLC (\"VV III\") is the sole general partner of VVC III. The Reporting Person, a member of the Issuer's board of directors, is a managing member of VV III and may be deemed to share voting and dispositive power over the shares held by VVC III. Each of VV III and the Reporting Person disclaims beneficial ownership of the shares held by VVC III, except to the extent of their respective pecuniary interests therein."}],"balance_after":994129,"source":{"system":"sec-edgar","filing":"0000899243-21-002552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000089924321002552/doc4.xml","form_type":"4"}},{"id":3111654,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-12T16:13:56.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-036251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036251/doc4.xml","form_type":"4"}},{"id":3111653,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T16:13:56.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":30004,"source":{"system":"sec-edgar","filing":"0001209191-20-036251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036251/doc4.xml","form_type":"4"}},{"id":3213779,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T01:28:22.000Z","date":"2020-03-11","kind":"purchase","acquired":true,"shares":10000,"price":2.6545,"value":26545.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the transactions reported is between $2.645 and $2.67 per share. $2.6545 represents the weighted average purchase price per share. The Reporting Person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":161109,"source":{"system":"sec-edgar","filing":"0001162194-20-000027","document":"wf-form4_158406288398220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000027/wf-form4_158406288398220.xml","form_type":"4"}},{"id":3213778,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T01:28:22.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":10000,"price":2.7738,"value":27738.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the transactions reported is between $2.755 and $2.78 per share. $2.7738 represents the weighted average purchase price per share. The Reporting Person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":151109,"source":{"system":"sec-edgar","filing":"0001162194-20-000027","document":"wf-form4_158406288398220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000027/wf-form4_158406288398220.xml","form_type":"4"}},{"id":3286704,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-07T00:00:35.000Z","date":"2020-02-04","kind":"grant","acquired":true,"shares":21628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units that vest in four equal quarterly installments beginning March 31, 2020."}],"balance_after":141109,"source":{"system":"sec-edgar","filing":"0001162194-20-000003","document":"wf-form4_158103361803794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000003/wf-form4_158103361803794.xml","form_type":"4"}},{"id":3427454,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-29T01:13:59.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":2000,"price":5.1859,"value":10371.8,"ownership":{"direct":true},"balance_after":119481,"source":{"system":"sec-edgar","filing":"0001162194-19-000086","document":"wf-form4_156704121821246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000086/wf-form4_156704121821246.xml","form_type":"4"}},{"id":3441334,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T20:57:35.000Z","date":"2019-08-08","kind":"purchase","acquired":true,"shares":1000,"price":6.6533,"value":6653.3,"ownership":{"direct":true},"balance_after":117481,"source":{"system":"sec-edgar","filing":"0001162194-19-000074","document":"wf-form4_156564343873081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000074/wf-form4_156564343873081.xml","form_type":"4"}},{"id":3442380,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-09T16:05:41.000Z","date":"2019-08-08","kind":"purchase","acquired":true,"shares":2000,"price":10.74,"value":21480.0,"ownership":{"direct":false,"nature":"By the Colella Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $10.74, and the range of prices were between $10.735 and $10.74.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 (\"Colella Trust\"). The Reporting Person is a trustee and beneficiary of the Colella Trust."}],"balance_after":45333,"source":{"system":"sec-edgar","filing":"0001209191-19-045325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119045325/doc4.xml","form_type":"4"}},{"id":3443710,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-09T01:04:38.000Z","date":"2019-08-07","kind":"purchase","acquired":true,"shares":1000,"price":6.8567,"value":6856.7,"ownership":{"direct":true},"balance_after":116481,"source":{"system":"sec-edgar","filing":"0001162194-19-000071","document":"wf-form4_156531266138292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000071/wf-form4_156531266138292.xml","form_type":"4"}},{"id":3443709,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-09T01:04:38.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":8000,"price":7.0229,"value":56183.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the transactions reported is between $7.01 and $7.03 per share. $7.0229 represents the weighted average purchase price per share. Reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":115481,"source":{"system":"sec-edgar","filing":"0001162194-19-000071","document":"wf-form4_156531266138292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000071/wf-form4_156531266138292.xml","form_type":"4"}},{"id":3480261,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":10600,"price":5.57,"value":59042.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Option vested and became exercisable in twelve equal monthly increments and was fully exercisable on May 31, 2019."}],"balance_after":0,"derivative":{"exercise_price":5.57,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480260,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":5000,"price":3.43,"value":17150.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Option vested and became exercisable in twelve equal monthly increments and was fully exercisable on August 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":3.43,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480259,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":3000,"price":5.44,"value":16320.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Option vested and became exercisable in twelve equal monthly increments and was fully exercisable on August 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":5.44,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480258,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":5000,"price":10.45,"value":52250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option vested and became exercisable in twelve equal monthly increments and was fully exercisable on August 3, 2017."}],"balance_after":0,"derivative":{"exercise_price":10.45,"expiration_date":"2026-08-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480257,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":10600,"price":5.57,"value":59042.0,"ownership":{"direct":true},"balance_after":107481,"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480256,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":5000,"price":3.43,"value":17150.0,"ownership":{"direct":true},"balance_after":96881,"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480255,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":3000,"price":5.44,"value":16320.0,"ownership":{"direct":true},"balance_after":91881,"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3480254,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T01:14:02.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":5000,"price":10.45,"value":52250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects an aggregate of 15,877 shares that were reported in prior Forms 4 as being directly held and are now being reported as indirectly held. Of such 15,877 shares, (i) 10,877 shares were transferred to the Colella Family Exempt Marital Deduction Trust dated 9/21/1992 (the \"Trust\") for no consideration on July 25, 2016, and (ii) 5,000 shares were acquired by the Trust in an open market purchase on December 14, 2016, that was erroneously reported as a direct ownership transaction."}],"balance_after":88881,"source":{"system":"sec-edgar","filing":"0001162194-19-000060","document":"wf-form4_156142522706670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000060/wf-form4_156142522706670.xml","form_type":"4"}},{"id":3481221,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-21T16:08:33.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":11.74,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-038458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119038458/doc4.xml","form_type":"4"}},{"id":3500863,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-05T17:40:11.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":6796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019."}],"balance_after":6796,"derivative":{"exercise_price":13.41,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":6796},"source":{"system":"sec-edgar","filing":"0001162194-19-000051","document":"wf-form4_155975638004967.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000051/wf-form4_155975638004967.xml","form_type":"4"}},{"id":3500862,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T17:40:11.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":3987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":99758,"source":{"system":"sec-edgar","filing":"0001162194-19-000051","document":"wf-form4_155975638004967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000051/wf-form4_155975638004967.xml","form_type":"4"}},{"id":3657041,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-15T02:03:04.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":9748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2019."}],"balance_after":95771,"source":{"system":"sec-edgar","filing":"0001162194-19-000007","document":"wf-form4_155019617000141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000007/wf-form4_155019617000141.xml","form_type":"4"}},{"id":3886003,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-21T16:14:10.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":28.14,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-038934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118038934/doc4.xml","form_type":"4"}},{"id":3911043,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-02T00:55:43.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on May 31, 2019."}],"balance_after":10600,"derivative":{"exercise_price":5.57,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001162194-18-000076","document":"wf-form4_152790093026108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000076/wf-form4_152790093026108.xml","form_type":"4"}},{"id":3911042,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-02T00:55:43.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-18-000076","document":"wf-form4_152790093026108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000076/wf-form4_152790093026108.xml","form_type":"4"}},{"id":3911041,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-02T00:55:43.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-18-000076","document":"wf-form4_152790093026108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000076/wf-form4_152790093026108.xml","form_type":"4"}},{"id":3911040,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-02T00:55:43.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"shares","element":"transactionShares","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) May 31, 2019, in each case subject to recipient's continued service as a director through the applicable vest date."}],"balance_after":86023,"source":{"system":"sec-edgar","filing":"0001162194-18-000076","document":"wf-form4_152790093026108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000076/wf-form4_152790093026108.xml","form_type":"4"}},{"id":3911039,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-02T00:55:43.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79923,"source":{"system":"sec-edgar","filing":"0001162194-18-000076","document":"wf-form4_152790093026108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000076/wf-form4_152790093026108.xml","form_type":"4"}},{"id":3911038,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-02T00:55:43.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76923,"source":{"system":"sec-edgar","filing":"0001162194-18-000076","document":"wf-form4_152790093026108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000076/wf-form4_152790093026108.xml","form_type":"4"}},{"id":4055265,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-15T22:53:31.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":12830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2018."}],"balance_after":71923,"source":{"system":"sec-edgar","filing":"0001162194-18-000013","document":"wf-form4_151873519713080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000013/wf-form4_151873519713080.xml","form_type":"4"}},{"id":4112788,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-03T21:52:22.000Z","date":"2017-12-31","kind":"exercise","acquired":false,"shares":7848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2017-12-31","underlying":"Common Stock","underlying_shares":7848},"source":{"system":"sec-edgar","filing":"0001162194-18-000007","document":"wf-form4_151501632861387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000007/wf-form4_151501632861387.xml","form_type":"4"}},{"id":4112787,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:52:22.000Z","date":"2017-12-31","kind":"exercise","acquired":true,"shares":7848,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":59093,"source":{"system":"sec-edgar","filing":"0001162194-18-000007","document":"wf-form4_151501632861387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000007/wf-form4_151501632861387.xml","form_type":"4"}},{"id":4112786,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:52:22.000Z","date":"2017-12-28","kind":"gift","acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51245,"source":{"system":"sec-edgar","filing":"0001162194-18-000007","document":"wf-form4_151501632861387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000007/wf-form4_151501632861387.xml","form_type":"4"}},{"id":4197925,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-10-03T00:56:09.000Z","date":"2017-09-30","kind":"exercise","acquired":false,"shares":7848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017 subject to serving as a director through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017 subject to serving as a director through such date."}],"balance_after":7848,"derivative":{"exercise_date":"2017-09-30","underlying":"Common Stock","underlying_shares":7848},"source":{"system":"sec-edgar","filing":"0001162194-17-000155","document":"wf-form4_150699215427384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000155/wf-form4_150699215427384.xml","form_type":"4"}},{"id":4197924,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T00:56:09.000Z","date":"2017-09-30","kind":"exercise","acquired":true,"shares":7848,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53045,"source":{"system":"sec-edgar","filing":"0001162194-17-000155","document":"wf-form4_150699215427384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000155/wf-form4_150699215427384.xml","form_type":"4"}},{"id":4209518,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-15T01:07:27.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the total number of shares subject to the Option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the Option will be fully vested one year following the Vesting Commencement Date, subject to recipient continuing to serve as a director of the Company through each such vesting date. \"Vesting Commencement Date\" shall mean August 1, 2017."}],"balance_after":3000,"derivative":{"exercise_price":5.44,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-17-000133","document":"wf-form4_150543763281417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000133/wf-form4_150543763281417.xml","form_type":"4"}},{"id":4209517,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-09-15T01:07:27.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-17-000133","document":"wf-form4_150543763281417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000133/wf-form4_150543763281417.xml","form_type":"4"}},{"id":4237932,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-10T20:43:32.000Z","date":"2017-08-08","kind":"grant","acquired":true,"shares":15696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units will vest on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017, in each case subject to serving as a director through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units will vest on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017, in each case subject to serving as a director through such date."}],"balance_after":15696,"derivative":{"underlying":"Common Stock","underlying_shares":15696},"source":{"system":"sec-edgar","filing":"0001162194-17-000108","document":"wf-form4_150239779812662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000108/wf-form4_150239779812662.xml","form_type":"4"}},{"id":4240228,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-09T00:30:33.000Z","date":"2017-08-08","kind":"purchase","acquired":true,"shares":35895,"price":2.768,"value":99357.36,"ownership":{"direct":false,"nature":"Colella Family Exempt Marital Deduction Trust dated 9/21/1992"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $2.55 to $3.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":53395,"source":{"system":"sec-edgar","filing":"0001162194-17-000095","document":"wf-form4_150223861967481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000095/wf-form4_150223861967481.xml","form_type":"4"}},{"id":4245945,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-03T00:39:08.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 1, 2018."}],"balance_after":5000,"derivative":{"exercise_price":3.43,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-17-000088","document":"wf-form4_150172073507202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000088/wf-form4_150172073507202.xml","form_type":"4"}},{"id":4245944,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-03T00:39:08.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director  through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director  through the vesting date."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-17-000088","document":"wf-form4_150172073507202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000088/wf-form4_150172073507202.xml","form_type":"4"}},{"id":4245943,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-03T00:39:08.000Z","date":"2017-07-31","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2017-07-31","expiration_date":"2017-07-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-17-000088","document":"wf-form4_150172073507202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000088/wf-form4_150172073507202.xml","form_type":"4"}},{"id":4245942,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-03T00:39:08.000Z","date":"2017-07-31","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45197,"source":{"system":"sec-edgar","filing":"0001162194-17-000088","document":"wf-form4_150172073507202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000088/wf-form4_150172073507202.xml","form_type":"4"}},{"id":4249998,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-27T09:37:24.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":20.16,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-046389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919117046389/doc4.xml","form_type":"4"}},{"id":4291003,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-06-06T18:49:40.000Z","date":"2017-06-05","kind":"purchase","acquired":true,"shares":5000,"price":17.0095,"value":85047.5,"ownership":{"direct":false,"nature":"By the Colella Family Exempt Marital Deduction Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $17.0095, and the range of prices were between $16.98 and $17.06.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Colella Family Exempt Marital Deduction Trust Dated 9/21/1992 (\"Colella Exempt Trust\"). The Reporting Person is a trustee and beneficiary of the Colella Exempt Trust."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-17-038222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919117038222/doc4.xml","form_type":"4"}},{"id":4303173,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T21:24:32.000Z","date":"2017-05-24","kind":"other","acquired":true,"shares":3326,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Colella Family Non-Exempt Marital Deduction Trust dated 9/21/1992"},"balance_after":3326,"source":{"system":"sec-edgar","filing":"0001162194-17-000060","document":"wf-form4_149583385843039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000060/wf-form4_149583385843039.xml","form_type":"4"}},{"id":4303172,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T21:24:32.000Z","date":"2017-05-24","kind":"other","acquired":false,"shares":3326,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40197,"source":{"system":"sec-edgar","filing":"0001162194-17-000060","document":"wf-form4_149583385843039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000060/wf-form4_149583385843039.xml","form_type":"4"}},{"id":4325058,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-11T22:08:22.000Z","date":"2017-05-09","kind":"purchase","acquired":true,"shares":7500,"price":5.925,"value":44437.5,"ownership":{"direct":false,"nature":"Colella Family Exempt Marital Deduction Trust dated 9/21/1992"},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001162194-17-000044","document":"wf-form4_149454048867838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000044/wf-form4_149454048867838.xml","form_type":"4"}},{"id":4384563,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-15T18:24:24.000Z","date":"2017-03-14","kind":"purchase","acquired":true,"shares":10000,"price":4.9973,"value":49973.0,"ownership":{"direct":false,"nature":"Colella Family Exempt Marital Deduction Trust dated 9/21/1992"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.930 to $5.030, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.930 to $5.030, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-17-002596","document":"wf-form4_148960224888190.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000162828017002596/wf-form4_148960224888190.xml","form_type":"4"}},{"id":4514362,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-21T19:10:21.000Z","date":"2016-12-20","kind":"gift","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43523,"source":{"system":"sec-edgar","filing":"0001162194-16-000264","document":"wf-form4_148234740846206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219416000264/wf-form4_148234740846206.xml","form_type":"4"}},{"id":4522267,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-15T00:05:05.000Z","date":"2016-12-14","kind":"purchase","acquired":true,"shares":5000,"price":7.387,"value":36935.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $7.36 to $7.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $7.36 to $7.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":44123,"source":{"system":"sec-edgar","filing":"0001162194-16-000262","document":"wf-form4_148176029311514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219416000262/wf-form4_148176029311514.xml","form_type":"4"}},{"id":4533212,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-05T14:40:51.000Z","date":"2016-12-01","kind":"purchase","acquired":true,"shares":10000,"price":16.3807,"value":163807.0,"ownership":{"direct":false,"nature":"By Colella Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $16.3807, and the range of prices were between $16.15 and $16.56.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 (\"Colella Trust\"). The Reporting Person is a trustee and beneficiary of the Colella Trust."}],"balance_after":43333,"source":{"system":"sec-edgar","filing":"0001209191-16-153270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919116153270/doc4.xml","form_type":"4"}},{"id":4535533,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T21:18:08.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":20000,"price":6.3235,"value":126470.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $6.17 to $6.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $6.17 to $6.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":39123,"source":{"system":"sec-edgar","filing":"0001162194-16-000259","document":"wf-form4_148071347603101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219416000259/wf-form4_148071347603101.xml","form_type":"4"}},{"id":4535532,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T21:18:08.000Z","date":"2016-03-15","kind":"gift","acquired":false,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19123,"source":{"system":"sec-edgar","filing":"0001162194-16-000259","document":"wf-form4_148071347603101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219416000259/wf-form4_148071347603101.xml","form_type":"4"}},{"id":4544876,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":133272,"kind":"person","name":"COLELLA SAMUEL D","position":1,"cik":"0001201580","reported_name":"COLELLA SAMUEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T18:40:11.000Z","date":"2016-11-21","kind":"purchase","acquired":true,"shares":33333,"price":18,"value":599994.0,"ownership":{"direct":false,"nature":"By Colella Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 (\"Colella Trust\"). The Reporting Person is a trustee and beneficiary of the Colella Trust."}],"balance_after":33333,"source":{"system":"sec-edgar","filing":"0001209191-16-151796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919116151796/doc4.xml","form_type":"4"}}]}